140 related articles for article (PubMed ID: 35537484)
1. Improved diagnosis of type-1 diabetes mellitus using multiplexed autoantibodies ELISA array.
Zhang D; Huang J; Hu J
Anal Biochem; 2022 Jul; 649():114722. PubMed ID: 35537484
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a new enzyme-linked immunosorbent assay system for three islet cell autoantibodies in Japanese patients with acute-onset type 1 diabetes.
Fukui T; Takehana N; Mori Y; Hiromura M; Terasaki M; Kushima H; Takada M; Tomoyasu M; Sato N; Hayashi T; Ohara M; Kikuchi T; Ito Y; Kobayashi T; Yamagishi SI
Endocr J; 2022 Nov; 69(11):1343-1349. PubMed ID: 35753761
[TBL] [Abstract][Full Text] [Related]
3. Pancreas Islet Cell-Specific Antibody Detection by ELISA.
Van Aelst S; Gillard P; Weets I; Dillaerts D; Billen J; Mathieu C; Bossuyt X
J Appl Lab Med; 2022 Jan; 7(1):66-74. PubMed ID: 34996082
[TBL] [Abstract][Full Text] [Related]
4. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
[TBL] [Abstract][Full Text] [Related]
5. Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes.
Kawasaki E; Shimada A; Imagawa A; Abiru N; Awata T; Oikawa Y; Osawa H; Kawabata Y; Kozawa J; Kobayashi T; Takahashi K; Chujo D; Fukui T; Miura J; Yasuda K; Yasuda H; Kajio H; Hanafusa T; Ikegami H;
J Diabetes Investig; 2023 Jan; 14(1):58-66. PubMed ID: 36177861
[TBL] [Abstract][Full Text] [Related]
6. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
Andersson C; Larsson K; Vaziri-Sani F; Lynch K; Carlsson A; Cedervall E; Jönsson B; Neiderud J; Månsson M; Nilsson A; Lernmark A; Elding Larsson H; Ivarsson SA
Autoimmunity; 2011 Aug; 44(5):394-405. PubMed ID: 21244337
[TBL] [Abstract][Full Text] [Related]
7. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
[TBL] [Abstract][Full Text] [Related]
10. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
[TBL] [Abstract][Full Text] [Related]
11. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
Takehana N; Fukui T; Mori Y; Hiromura M; Terasaki M; Ohara M; Takada M; Tomoyasu M; Ito Y; Kobayashi T; Yamagishi SI
J Diabetes Investig; 2023 Jul; 14(7):856-863. PubMed ID: 37082800
[TBL] [Abstract][Full Text] [Related]
12. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
13. 3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD
Amoroso M; Achenbach P; Powell M; Coles R; Chlebowska M; Carr L; Furmaniak J; Scholz M; Bonifacio E; Ziegler AG; Rees Smith B
Clin Chim Acta; 2016 Nov; 462():60-64. PubMed ID: 27570064
[TBL] [Abstract][Full Text] [Related]
14. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
[TBL] [Abstract][Full Text] [Related]
15. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
16. Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease.
Lind A; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Agardh D; Larsson HE; Lundgren M; Tsai CT; Lernmark Å
J Immunol Methods; 2022 Jul; 506():113265. PubMed ID: 35358496
[TBL] [Abstract][Full Text] [Related]
17. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
18. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
[TBL] [Abstract][Full Text] [Related]
19. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
[TBL] [Abstract][Full Text] [Related]
20. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]